Learn more about our recent advances
Disease Area
Discovery
Outlicensed
Preclinical
Clinical
Commercial
Oncology (3 assets)
CNS (3 assets)
T2D (22 assets)
Repurposed Drug
New Molecular Entity
Learn more about the innovators on the forefront of biomedical AI research
